Clinical trial
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid…
NCT00049608 · National Center for Complementary and Integrative Health (NCCIH), NIH · Terminated
Key facts
| NCT number | NCT00049608 |
|---|---|
| Title | Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study Of The Effect Of Mistletoe Extract, A Complementary Medicine Botanical, On Pharmacokinetics, Pharmacodynamics And Safety Of Gemcitabine In Patients With Advanced Solid Tumors |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | mistletoe extract, gemcitabine hydrochloride |
| Enrollment | 51 |
| Start date | Jul 1, 2002 |
| Completion | Aug 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: